Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases
Interstitial lung diseases (ILDs) are some of the first and most serious complications of connective tissue diseases (CTDs). However, the pathogenesis of CTD-related ILDs (CTD-ILDs) is still unclear and their treatment often depends on functional and radiographic disease progression as well as on pa...
Saved in:
Main Authors: | Valeria Nucera (Author), Elisabetta Gerratana (Author), Manuela Giallanza (Author), Laura La Corte (Author), Donatella Sangari (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
by: Gian Luca Erre, et al.
Published: (2021) -
Interstitial lung disease in mixed connective tissue disease
by: Marshell Tendean, et al.
Published: (2017) -
Efficacy and safety of Chinese herbal medicines combined with cyclophosphamide for connective tissue disease-associated interstitial lung disease: A meta-analysis of randomized controlled trials
by: Xietian Yin, et al.
Published: (2023) -
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
by: Caterina Vacchi, et al.
Published: (2021) -
Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: Case report and review of literature
by: Sfriso Paolo, et al.
Published: (2011)